Advertisement
U.S. Markets close in 3 hrs 20 mins

Hangzhou Tigermed Consulting Co., Ltd (5HZ1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
3.8800-0.0800 (-2.02%)
As of 09:15AM CET. Market open.
Full screen
Previous Close3.9600
Open3.9800
Bid3.9600 x N/A
Ask4.2000 x N/A
Day's Range3.8800 - 3.9800
52 Week Range2.7600 - 5.2500
Volume0
Avg. Volume2
Market Cap6.678B
Beta (5Y Monthly)0.85
PE Ratio (TTM)25.87
EPS (TTM)0.1500
Earnings DateOct 29, 2024
Forward Dividend & Yield0.07 (1.84%)
Ex-Dividend DateJun 07, 2024
1y Target EstN/A
  • PR Newswire

    Tigermed Reports 2024 Interim Results

    Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its interim results for the first half of 2024, ended June 30, 2024 (the "Reporting Period").

  • Zacks

    Veeva Systems' (VEEV) Vault EDC to Boost Tigermed's Workflow

    Veeva Systems' (VEEV) Vault EDC is likely to streamline key processes to accelerate study builds and make mid-study amendments with no downtime.